MDM2 was also needed to sustain MYCN in two TP53-mutant SCLC cell lines, in keeping with the critical role of MDM2 in TP53-mutant as well as wild type neuroblastoma and retinoblastoma cells. Here, TP53 is linked to small cell lung carcinoma.